Prognostic factors of survival in patients treated with nab-paclitaxel plus gemcitabine regimen for advanced or metastatic pancreatic cancer: A single institutional experience

PURPOSE: The objectives of this study were to evaluate the effectiveness of nab-paclitaxel plus gemcitabine (NAB-P/GEM) regimen in an unselected population of patients with advanced inoperable or metastatic pancreatic cancer (PC), and to identify the prognostic factors influencing overall survival (...

Descripción completa

Detalles Bibliográficos
Autores principales: Lo Re, Giovanni, Santeufemia, Davide A., Foltran, Luisa, Bidoli, Ettore, Basso, Stefano M.M., Lumachi, Franco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480749/
https://www.ncbi.nlm.nih.gov/pubmed/25779664

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480749/
https://www.ncbi.nlm.nih.gov/pubmed/25779664

Ejemplares similares